@conference{308240f80e8944d3bae86c50a6f52ba9,
title = "Persistent Reductions in OCS Use in Patients With Severe, OCS-Dependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study",
author = "Mark Gurnell and Christian Domingo and Rabe, {Klaus F} and Andrew Menzies-Gow and David Price and Guy Brusselle and Wechsler, {Michael E} and Changming Xia and Michel Djandji and Rebecca Gall and JacobNara, {Juby A.} and Rowe, {Paul J.} and Yamo Deniz and Shahid Siddiqui",
note = "Acknowledgments and funding sources Data first presented at the 118th International Conference of the American Thoracic Society (ATS 2022); San Francisco, CA, USA; May 13–18, 2022. Research sponsored by Sanofi and Regeneron Pharmaceuticals, Inc. ClinicalTrials.gov Identifiers: NCT02528214 (VENTURE)/NCT02134028 (TRAVERSE). Medical writing/editorial assistance was provided by Anthony Aggidis, PhD, of Excerpta Medica, and was funded by Sanofi and Regeneron Pharmaceuticals, Inc., according to the Good Publication Practice guideline. Alternate presenters: Anne Atenhan and Mayank Thakur. ; 17th Annual Deutscher Allergiekongress (DAK) 2022, 17th Annual Deutscher Allergiekongress (DAK) 2022 ; Conference date: 08-09-2022 Through 10-09-2022",
year = "2022",
month = jul,
day = "28",
language = "English",
url = "https://allergiekongress.de/",
}